-Rony Seger Researcher Activity Profile

Research Author Detailed Information 

Rony Seger Publication Rate By Year

Rony Seger has published 1 paper(s) in 1986, 1 paper(s) in 1989, 1 paper(s) in 2004, 7 paper(s) in 2007, 10 paper(s) in 2008, for a total of 20 research publications in total.

Rony R Seger Author Information

LAST NAME: seger

FIRST NAME: Rony

INITIALS: r

AFFILIATION:

Papers

Rony Seger's Publication Record

1. SB203580 Induces Prolonged B-Raf Activation and Promotes Neuronal Differentiation upon EGF Treatment of PC12 Cells. Year Published: 2004
Bioanalysis and Biotransformation Research Center, Korean Institute of Science and Technology, Cheongryang, Seoul, 130-650, Republic of Korea. ysyoo@kist.re.kr
2. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Year Published: 2007
The Chaim Sheba Medical Center, Department of Oncology, Tel Hashomer, Israel.
3. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Year Published: 2007
Department of Internal Medicine, National Reference Laboratory for Histocompatibility, University Hospital, Geneva, Switzerland. jean-marie.tiercy@medecine.unige.ch
4. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Year Published: 2007
Division of Immunology, Children's Hospital, Boston, MA 02115, USA. faif.geha@childrens.harvard.edu
5. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Year Published: 2007
6. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Year Published: 2007
7. Progress and prospects: gene therapy clinical trials (part 1). Year Published: 2007
8. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Year Published: 2007
The Chaim Sheba Medical Center, Department of Oncology, Tel Hashomer, Israel.
9. Immunological detection of phosphorylation. Year Published: 2008
The Weizmann Institute of Science, Rehovot, Israel.
10. Immunological detection of phosphorylation. Year Published: 2008
The Weizmann Institute of Science, Rehovot, Israel.
11. The detection of MAPK signaling. Year Published: 2008
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
12. The detection of MAPK signaling. Year Published: 2008
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
13. Meeting Report: Receptor tyrosine kinases: the emerging tip of systems control. Year Published: 2008
Weizmann Institute of Science, Department of Biological Regulation, Rehovot, IsraelThomas Jefferson University, Department of Dermatology and Cutaneous Biology, Philadelphia, USA.
14. The detection of MAPK signaling. Year Published: 2008
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
15. [Suspected diagnosis of immunodeficiency. Study program in the evaluation of children with recurrent infections] Year Published: 1986
16. [Immunological basis of IgE-mediated allergies. A contribution to the understanding of new therapy forms] Year Published: 1989
17. The detection of MAPK signaling. Year Published: 2008
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
18. The detection of MAPK signaling. Year Published: 2008
Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.
19. Receptor tyrosine kinases: the emerging tip of systems control. Year Published: 2008
Department of Biological Regulation, Weizmann Institute of Science, , Rehovot, Israel. rony.seger@weizmann.ac.il
20. Distinct pathways for the involvement of WNK4 in the signaling of hypertonicity and EGF. Year Published: 2008
Laboratory of Biochemical Pharmacology, Sheba Medical Center, Tel Hashomer, Israel, and Nephrology Institute, Sheba Medical Center, Tel Hashomer, Israel.